ABOUT US
ABOUT
We are dedicated to the goal of preserving a person’s function and quality of life into old age. Our drug attacks neurodegeneration at its roots
QR Pharma is a specialty pharmaceutical company developing novel treatments for Alzheimer’s, Parkinson’s and other neurodegenerative diseases. QR is attacking neurodegeneration at its roots with its product candidate Posiphen® which inhibits the production of brain toxic proteins.
DISEASE FOCUS
OUR FOCUSNeurodegenerative diseases are the largest unmet need for our aging population, our economy and the world. QR Pharma understands how brain cells die in both slow chronic & fast acute injuries to the brain and the nervous system
Alzheimer’s Disease (AD) A type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks.
Alzheimer’s Disease
5,400,000
Estimated people in the US have Alzheimer’s disease (AD)
Parkinson’s disease (PD): A chronic and progressive movement disorder, meaning that symptoms continue and worsen over time. It involves the malfunction and death of vital nerve cells in the brain, called neurons.
Parkinsons’s Disease
1,000,000
Estimated people in the US have Parkinson’s disease (AD)
INNOVATION
INNOVATIONAttacking Neurodegeneration at it’s Roots
Posiphen®
QR Pharma’s lead compound, Posiphen® inhibits synthesis of amyloid precursor protein (APP), Tau and α-Synuclein. Posiphen® is distinct from other Alzheimer’s disease (AD) drugs currently in development, because it inhibits the formation of toxic proteins before they are formed
Our Pipeline
- Alzheimer’s disease: QR is starting a 1 month phase IIa study in mild to moderate Alzheimer
patients in June and expects the data to be available at the beginning of 2017 - Parkinson’s disease: human safety was completes
- Traumatic brain injury: human safety was completed
PRESS ROOM
BEHIND THE SCIENCEWhat is happening at QR Pharma
Press Release
Maria Maccecchini to Receive 2011 Iris...
Maria Maccecchini to Receive 2011 Iris Newmann Award – November 16, 2011 Article >>>>> News Articles
Healthcare Businesswomen’s Association: Women in Science...
Healthcare Businesswomen’s Association: Women in Science – Winter 2011 Scientific Presentations
Targeting Alzheimer’s and Other Neurodegenerative Diseases...
Speaker: Maria L. Maccecchini Presentation, November 30, 2010. CNDR Talk: University of Pennsylvania, More >>>>> Scientific Publications
NeuroScience Network – Is Alzheimer’s Disease...
NeuroScience Network – Is Alzheimer’s Disease Close To Being Cured? – May 11, 2010